Budd-Chiari syndrome associated with hypereosinophilic syndrome; a case report

Internal Medicine

Volumn 46, Issue 14, 2007, Pages 1095-1100

  Inoue, Ai ^a   Michitaka, Kojiro ^a   Shigematsu, Shuichiro ^a,b   Konishi, Ichiro ^a   Hirooka, Masashi ^a   Hiasa, Yoichi ^a   Matsui, Hidetaka ^a   Matsuura, Bunzo ^a   Horiike, Norio ^a   Hato, Takaaki ^a   Miyaoka, Hiroaki ^b   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Matsuyama Hospital   (Japan)

Author keywords

Budd Chiari syndrome; FIP1 like 1 (FIP1L1) gene; Hypereosinophilic syndrome; Obstructive thrombophlebitis; Platelet derived growth factor receptor (PDGFRA) genes

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; STEROID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FIP1L1; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ANGIOGRAPHY; ARTICLE; ASCITES; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EOSINOPHIL; EOSINOPHILIA; GENE FUSION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFERIOR CAVA VEIN OBSTRUCTION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER VEIN OBSTRUCTION; MALE; STEROID THERAPY; SUBCUTANEOUS NODULE; THROMBOPHLEBITIS; TREATMENT OUTCOME; VEIN DILATATION;

ADULT; HEPATIC VEIN THROMBOSIS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; TREATMENT OUTCOME;

EID: 34548438140     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6438     Document Type: Article

References (30)

1. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 22: 15-26, 2002.
2. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28: 1191-1198, 1998.
3. De BK, De KK, Sen S, et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India 48: 800-803, 2000.
4. Singh V, Sinha SK, Nain CK, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 15: 550-554, 2000.
5. Kage M, Arakawa M, Kojiro M, Okuda K. Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology 102: 2081-2090, 1992.
6. Okuda H, Yamagata H, Obata H, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 22: 1-9, 1995.
7. Saisse J, Hardwigsen J, Castellani P, Caus T, Le Treut YP. Budd-Chiari syndrome secondary to intracardiac extension of hepatocellular carcinoma. Two cases treated by radical resection. Hepatogastroenterology 48: 836-839, 2001.
8. Chatel. D, Nottin R, Zeitoun G, Dazza F, Hay JM, Plessis-Robinson L. Budd-Chiari syndrome secondary to carcinoma: report of two cases. Ann Vasc Surg 9: 565-570, 1995.
9. Bachleitner-Hofmann T, Grumbeck E, Gisslinger H. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective an analysis of 15 patients. Thromb Res 112: 229-232, 2003.
10. Cervantes F, Barosi G, Hernandez-Boluda JC, Marchetti M, Montserrat E. Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: presenting features, evolution and survival. Eur J Haematol 66: 324-327, 2001.
11. Acharya J, Westwood NB, Sawyer BM, et al. Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol 55: 315-321, 1995.
12. Van Steenbergen W, Beyls J, Vermylen J, et al. 'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. J Hepatol 3: 87-94, 1986.
13. Pelletier S, Landi B, Piette JC, et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 21: 76-80, 1994.
14. Zuazu-Jausoro I, Sanchez I, Fernandez MC, Corral J, Gonzalez-Conejero R, Vicente V. Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 A allele of the prothrombin gene. Haematologica 83: 1129-1130, 1998.
15. Delarive J, Gonvers JJ. Budd-Chiari syndrome related to factor V Leiden mutation. Am J Gastroenterol 93: 651-652, 1998.
16. Vogel J, Gorich J, Kramme E, et al. Alveolar echinococcosis of the liver: percutaneous stent therapy in Budd-Chiari syndrome. Gut 39: 762-764, 1996.
17. Bresson-Hadni S, Franza A, Miguet JP, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases. Hepatology 13: 1061-1070, 1991.
18. Leiferman KM. Hypereosinophilic syndrome. Semin Dermatol 14: 122-128, 1995.
19. Bain BJ. Relationship between idiopathic hypereosinophilic syndrome, eosinophihc leukemia, and systemic mastocytosis. Am J Hematol 77: 82-85, 2004.
20. Walker M. Idiopathic hypereosinophilia associated with hepatic vein thrombosis. Arch Intern Med 147: 2220-2221, 1987.
21. Zylberberg H, Valla D, Viguie F, Casadevall N. Budd-Chiari syndrome associated with 5q deletion and hyperesinophilia. J Clin Gastroenterol 23: 66-68, 1996.
22. Vargas CA, Maldonado O, Botero RC, et al. Budd-Chiari syndrome associated with the hypereosinophilic syndrome. Am J Gastroenterol 88: 1802-1803, 1993.
23. Suenaga N, Hayashi F, Miyauhi N, et al. A case of hypereosinophilic syndrome associated with pulmonary infarction and hepatic vein obstruction (Budd-Chiari syndrome). Nihon Kyobu Shikkan Gakkai Zasshi 29: 239-244, 1991 (in Japanese, Abstract in English).
24. Elouaer-Blanc L, Zafrani ES, Farcet JP, et al. Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. Arch Intern Med 145: 751-753, 1985.
25. Cools J, DeAngelo, DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214, 2003.
26. Baijal SS, Roy S, Phadke RV, Agrawal DK, Kumar S, Choudhuri G. Management of idiopathic Budd-Chiari syndrome with primary stent placement: early results. J Vasc Interv Radiol 7: 545-553, 1996.
27. Holland-Fischer P, Gronbaek H, Astrup L, Keiding S, Nielsen DT, Vilstrup H. Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt. Scand J Gastroenterol 39: 1025-1028, 2004.
28. Rinckenbach S, Chakfe N, Beaufigeau M, et al. Surgical treatment of a Budd-Chiari syndrome secondary to hepatic inferior vena cava agenesia. J Cardiovasc: Surg 43: 665-669, 2002.
29. Srinivasan P, Rela M, Prachalias A, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 73: 973-977, 2002.
30. Young ID, Clark RN, Manley PN, Groll A, Simon JB. Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology 94: 503-507, 1988.